FFA
MNTA

Fragasso Financial Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Fragasso Financial Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,000
Closed -$472K – 139
2020
Q3 		$472K Buy
+9,000
New +$373K 0.08% 84

Fragasso Financial Advisors's MNTA Position: Q4 2020 in Review

Fragasso Financial Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 9,000 shares — an estimated $472K sold.

Fragasso Financial Advisors first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $472K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Fragasso Financial Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Fragasso Financial Advisors sold 9,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $472K.
  • Fragasso Financial Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Fragasso Financial Advisors's Momenta Pharmaceuticals, Inc. position peaked at $472K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Fragasso Financial Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.